Pulike Biological Engineering, Inc.

XSSC:603566 Stock Report

Market Cap: CN¥4.0b

Pulike Biological Engineering Future Growth

Future criteria checks 4/6

Pulike Biological Engineering is forecast to grow earnings and revenue by 27.8% and 15.4% per annum respectively. EPS is expected to grow by 28.3% per annum. Return on equity is forecast to be 9% in 3 years.

Key information

27.8%

Earnings growth rate

28.3%

EPS growth rate

Pharmaceuticals earnings growth18.8%
Revenue growth rate15.4%
Future return on equity9.0%
Analyst coverage

Good

Last updated08 Sep 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

XSSC:603566 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261,697295N/A3896
12/31/20251,524251N/A3397
12/31/20241,354203N/A2707
6/30/20241,11813285257N/A
3/31/20241,1811383246N/A
12/31/20231,253175-22283N/A
9/30/20231,329225-144251N/A
6/30/20231,335204-213221N/A
3/31/20231,292194-148269N/A
12/31/20221,230168-129228N/A
9/30/20221,105142-124252N/A
6/30/20221,032161-90271N/A
3/31/20221,035195-129219N/A
12/31/20211,099244-105213N/A
9/30/20211,10229842245N/A
6/30/20211,08627135218N/A
3/31/20211,04425562245N/A
12/31/202092922885262N/A
9/30/202084017562218N/A
6/30/202076516484205N/A
3/31/202070915495191N/A
12/31/201966310955140N/A
9/30/201964811255136N/A
6/30/20196421241384N/A
3/31/20196121113591N/A
12/31/201860813673126N/A
9/30/201858014192135N/A
6/30/2018557129107159N/A
3/31/2018541119N/A134N/A
12/31/2017530114N/A141N/A
9/30/2017537124N/A218N/A
6/30/2017592160N/A209N/A
3/31/2017599178N/A225N/A
12/31/2016583188N/A253N/A
9/30/2016543181N/A206N/A
6/30/2016505161N/A193N/A
3/31/2016465139N/A187N/A
12/31/2015478142N/A187N/A
9/30/2015467152N/A166N/A
6/30/2015486158N/A165N/A
3/31/2015499161N/A148N/A
12/31/2014476140N/A151N/A
12/31/2013472163N/A181N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 603566's forecast earnings growth (27.8% per year) is above the savings rate (2.9%).

Earnings vs Market: 603566's earnings (27.8% per year) are forecast to grow faster than the CN market (22.9% per year).

High Growth Earnings: 603566's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 603566's revenue (15.4% per year) is forecast to grow faster than the CN market (13.1% per year).

High Growth Revenue: 603566's revenue (15.4% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 603566's Return on Equity is forecast to be low in 3 years time (9%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y